MediSieve wins 1st runner up at prestigious Boston Biotech Week start up competition
Medical device company, MediSieve, received
accolades for their ground breaking work during the Biotech Week held in Boston
in September 2018. MediSieve won first runner up for Best Business Plan at the
Xcelerate Startup Pitch Competition hosted by Xcelerate Insight and EBD Group.
The pitch competition is designed to give early stage companies exposure to
possible investors and partners. It is judged by top venture capitalists and
industry experts.
MediSieve is a medical device company whose
magnetic blood filtration system has the ability to specifically and
selectively remove disease-causing agents from the blood. The technology has
the potential to transform the treatment of blood borne diseases such as sepsis,
leukaemia and malaria.
George Frodsham, CEO at MediSieve explained that
"Our pioneering technology involves targeting specific components that
cause the diseases and removing them from the patient’s bloodstream. This
provides clinicians with a tool to target and remove infected cells, pathogens,
toxins, cytokines and others. We are delighted to have received the first
runner up award at the Xcelerate Startup Pitch Competition as we were up
against many other excellent entrepreneurs in the field of life science."
George explains how he started the company and the amazing potential of their
technology in this interview.
Along with 16 other entrepreneurs, MediSieve
presented at the Xcelerate Startup Pitch competition at BioPharm America
earlier this month. All the entrepreneurs presented major undertakings which
will have a major impact in life science. Each start up presented their
business, with visuals, to an audience which included a panel of investor
judges.
Only five of the startups in attendance received
an award, with RubrYcs Therapeutic winning the competition.
On the judging panel were: Cheryl Cui of
Nest.Bio Ventures, Janelle Anderson of Versant Ventures, Christine Brennan of
MRL Ventures Fund, Matthew Hammond of RA Capital Management, Stefan Vitorovic
of Vida Ventures, and Paulina Hill of Polaris Partners.
The first runners up were: for best pitch,
VisikolInc and for best business plan, MediSieve Limited. The second runners up
were: for best pitch, Envisagenics and for best business plan, Cairn
Biosciences.
More information about MediSieve and their
ground breaking magnetic blood filtration system can be found on their website
at www.medisieve.com.
For editorial
enquiries, contact 0131 357 8977 or email pr@redheadpr.co.uk
Follow redheadPR
on Twitter and like them
on Facebook
Visit www.redheadpr.co.uk
Find
out more about founder and managing director, Sara Tye